SCHEMBL12410060

SCHEMBL12410060

COC(=O)c1cc(N2CCCC2)nc(/C=C/c2cc(C)c3ccccc3n2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
POLB P06746 2/20 0.54
HPGD P15428 2/20 0.54
ALOX12 P18054 1/20 0.54
KDM4E B2RXH2 9/20 0.52
GAA P10253 3/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
ACHE P22303 1/20 0.51
PDE10A Q9Y233 1/20 0.50
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
USP2 O75604 1/20 0.45
PKM P14618 1/20 0.45
MAPT P10636 9/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 3/20 0.43
ADRB1 P08588 1/20 0.42
NCF1 P14598 1/20 0.42
TP53BP1 Q12888 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178013 0.83 PDE10A (0.46) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL2178021 0.83 PDE10A (0.46) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL12494686 0.83 KDM4E (0.60) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL7934247 0.81 KDM4E (0.60) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL12408670 0.77 KDM4E (0.36) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL2467305 0.72 ALDH1A1 (0.65) ALDH1A1POLBHPGDKDM4EGAA
SCHEMBL2176961 0.72 ALDH1A1 (0.47) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL2176953 0.72 ALDH1A1 (0.47) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL26723750 0.71 KDM4E (1.00) ALDH1A1POLBHPGDALOX12KDM4E
SCHEMBL2178481 0.70 ALDH1A1 (0.45) ALDH1A1POLBHPGDALOX12KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE PDE10A, PDE3A, PDE3B ALDH1A1 1520/4885POLB 2158/4885HPGD 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.